{
    "nctId": "NCT05115474",
    "briefTitle": "Study of Screening Brain MRIs in Stage IV Breast Cancer",
    "officialTitle": "Phase II Study of Screening Brain MRIs in Stage IV Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Triple Negative Breast Cancer, HER2-positive Breast Cancer, Hormone Receptor-positive Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Rate of Brain Metastasis",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologic diagnosis of breast cancer with documentation of ER/PR/HER2 status\n* Radiographic evidence of stage IV extracranial diease having progressed past first line therapy in HR+/HER2- patients\n* Radiographic evidence of stage IV extracranial disease in TN and HER2+ patients\n* Age \u2265 18\n* Life expectancy \u2265 6 months\n* Eastern Cooperative Oncology Group performance status 0 to 2\n* Patients must be able to understand and the willingness to sign an informed consent for study procedures\n* Stated willingness to comply with all study procedures and availability for the duration of the study\n\nExclusion Criteria:\n\n* Prior diagnosis or treatment of brain metastases or leptomeningeal disease\n* Patients with prior history of non-breast cancer malignancies should have no evidence of disease \u2265 2 years\n* Neurologic symptoms warranting standard screening brain MRI in the judgement of the treating physician at time of enrollment\n* Indications warranting brain MRI for other neurologic conditions at time of study entry\n* Contraindication towards MRI imaging with contrast\n* Chronic kidney disease stage IV or V or end stage renal disease",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}